Prescription drug prices fall 3.1 percent year over year, steepest drop since 1963

WASHINGTON - Prescription drug prices fell 3.1 percent from a year earlier, the steepest annual decline since 1963, according to price-index reporting carried by The National News Desk and local affiliates.

The Trump administration has tied the drop to greater price transparency, its most-favored-nation drug pricing push, and new discount tools meant to narrow the gap between U.S. list prices and what patients actually pay at the counter. President Trump has argued for years that Americans paid far more than patients in other developed countries for the same medicines.

Dr. Ryan Cole of the Independent Medical Alliance told The National News Desk the U.S. market is complicated by layers of middlemen, including insurers, pharmacies, and pharmacy benefit managers. Those layers, he said, make net prices opaque and often leave patients with higher final costs.

Cole said transparency can help patients compare a drug's list price with a real net or cash price. In some cases, paying cash can cost less than using insurance after rebates and fees are counted. He advised patients to ask doctors whether a generic exists and to ask pharmacists to check cash pricing options, including TrumpRx cash prices when offered.

Critics of sharp price cuts warn that squeezing manufacturer revenue could slow research on new treatments. Cole disputed that claim, saying lower consumer prices do not have to stop American medical innovation.

For households on Medicare or fixed incomes, a 3.1 percent year-over-year decline is welcome but uneven. Individual drug prices still vary by plan, pharmacy, and whether a medicine has a generic. Checking both insurance and cash quotes before filling a chronic prescription remains the practical next step.